Aim: It is aimed in this study to determine blood and blood component’s transfusion indications, component using rate, early transfusion complications and the distribution of complications according to the blood component. Method: In this study, recipient’s name, surname, age, gender, blood component, the clinic where transfusion have done, transfusion indications, whether or not transfusion hi...

Background: Recurrent blood transfusion is a common treatment in patients with thalassemia. The development of antibodies against red blood cell (RBC) antigens complicates RBC cross-matching, enhances the in vivo destruction of transfused cells, accelerates tissue iron overloading, delays the provision of safe transfusion, and reduces health-related quality of life. Materials and Methods: In t...

background and aims: cytomegalovirus (cmv) has worldwide distribution, and its prevalence rate depends on factors such as economic and geographical conditions. an important way of the virus transmission is via blood. due to high prevalence of anti-cmv antibodies in blood donors and lack of data concerning its seroprevalence in the region, this study was carried out to determine the prevalence r...

introduction: hypertension is described as one of the risk factors for cardiovascular disease. the prevalence of hypertension is growing among developing countries. in this study, the prevalence of hypertension was studied in individuals who referred to blood transfusion center of ilam city. materials and methods: the present descriptive analytical study was performed based on available data. t...

1 Bristol Institute for Transfusion Sciences, National Blood Service, Bristol, UK 2 Department of Transfusion Medicine, University Hospital, Ulm, Germany 3 Growing Your Knowledge, Split Junction, NSW, Australia 4 American Red Cross Blood Services, Southern California Region, Pomona, CA, USA 5 Reference Laboratory for Immunohematology and Blood Groups, Blood Services Center, Magen David Adom, Te...

background and objective: patients with thalassemia major have an abnormality in hemoglobin synthesis and ineffective hematopoiesis and for this reason with respect to disease severity should receive one or more fresh blood unit every 15-30 days. since transfusion of blood products has been known as one of the routes of hiv infection, therefore, this study was conducted to evaluate the prevalen...

conclusions: hydroxyurea can be safely used in some transfusion-dependent β-thalassemia patients to decrease their transfusion needs. background: β-thalassemia is an inherited hemoglobin disorder caused by defective synthesis of ß-globin chains. hemoglobin (hb) f induction is a possible therapeutic approach which can partially compensate for α and non-α globin chains imbalance. objectives: we a...

transfusion of blood and its components/derivatives is a life saving medical intervention. however, this life saving procedure depends mainly on the availability of sufficient blood and its components in national health sector. therefore the overall safety of transfusion medicines including the safety of blood and its available components and the appropriate use of these components would direct...

BACKGROUND Blood products and derivatives are indispensable resources in medical therapies. However, it is important to note that the number of donations is far from ideal. Despite constant campaign efforts, a deficit of 1 million units is expected by 2030. OBJECTIVES To determine the adequacy of the indications for red blood cell transfusion in an emergency hospital in Alagoas. METHODS Thi...